Jane Street’s Eterna Therapeutics ERNA Stock Holding History

Jane Street’s Portfolio ERNA Stock Details ERNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,647	Closed	-$8.19K	–	11942
2026 Q1	$8.19K	Buy	+1,647	New	+$26.3K	﹤0.01%	11320
2022 Q3	–	Sell	-3	Closed	-$10K	–	9870
2022 Q2	$10K	Buy	3 +1	+50%	+$7.18K	﹤0.01%	9309
2022 Q1	$27K	Sell	2 -3	-60%	-$56.9K	﹤0.01%	9860
2021 Q4	$145K	Buy	5 +3	+150%	+$163K	﹤0.01%	9023
2021 Q3	$148K	Buy	+2	New	+$173K	﹤0.01%	9069
2020 Q3	–	Sell	-1	Closed	-$48K	–	7313
2020 Q2	$48K	Buy	+1	New	+$21.7K	﹤0.01%	6873

Other funds holding ERNA

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

DIG

Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tradewinds Capital Management Bellingham, Washington $563M AUM 41.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Jane Street's ERNA Position: Q2 2026 in Review

Jane Street sold out of Eterna Therapeutics (ERNA) in Q2 2026, closing a stake of 1,647 shares — an estimated $8.19K sold.

Jane Street first reported a position in ERNA in Q2 2020 and held it in 6 quarters. The position peaked at $148K in Q3 2021. 9 funds tracked by Wall St. Rank hold ERNA as of Q2 2026.

Jane Street reported no remaining Eterna Therapeutics position as of Q2 2026 after selling out during the quarter.
Jane Street sold 1,647 Eterna Therapeutics shares in Q2 2026, an estimated $8.19K.
Jane Street first reported a position in Eterna Therapeutics in Q2 2020 and held it in 6 quarters.
Jane Street's Eterna Therapeutics position peaked at $148K in Q3 2021.
9 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.